Teachpic Logo

Table 1 From A Multicenter Phase Ii Study Of Docetaxel In Combination

Table 1 from A Multicenter Phase II Study of Docetaxel in Combination ...
Table 1 from A Multicenter Phase II Study of Docetaxel in Combination ...
Table 1 from A Phase II Study of Weekly Docetaxel in Combination with ...
Table 1 from A Phase II Study of Weekly Docetaxel in Combination with ...
Table 1 from A Phase II Study of Weekly Docetaxel for Patients with ...
Table 1 from A Phase II Study of Weekly Docetaxel for Patients with ...
Table 1 from Phase II study of weekly docetaxel in patients with ...
Table 1 from Phase II study of weekly docetaxel in patients with ...
Table 1 from A Phase II Study of Weekly Docetaxel as Second-Line ...
Table 1 from A Phase II Study of Weekly Docetaxel as Second-Line ...
Table 1 from A Phase Ib/II Study of Gemcitabine and Docetaxel in ...
Table 1 from A Phase Ib/II Study of Gemcitabine and Docetaxel in ...
Figure 1 from A Multicenter Randomized Phase II Study of Docetaxel vs ...
Figure 1 from A Multicenter Randomized Phase II Study of Docetaxel vs ...
Table 1 from A prospective multicenter phase II study of oral and i.v ...
Table 1 from A prospective multicenter phase II study of oral and i.v ...
Table 1 from A multicenter phase II study of gemcitabine and S-1 ...
Table 1 from A multicenter phase II study of gemcitabine and S-1 ...
Table 1 from Phase II study of docetaxel in patients with epithelial ...
Table 1 from Phase II study of docetaxel in patients with epithelial ...
Table 1 from Final results of a multicenter phase II study of the ...
Table 1 from Final results of a multicenter phase II study of the ...
Table 1 from A Phase II Study of Flavopiridol (Alvocidib) in ...
Table 1 from A Phase II Study of Flavopiridol (Alvocidib) in ...
Table 1 from Phase II Study with Docetaxel and Cisplatin in the ...
Table 1 from Phase II Study with Docetaxel and Cisplatin in the ...
Table 1 from A prospective multicentre phase II study of cisplatin and ...
Table 1 from A prospective multicentre phase II study of cisplatin and ...
Table 1 from A phase I/II study of the combination of quizartinib with ...
Table 1 from A phase I/II study of the combination of quizartinib with ...
A multi-institution phase II study of docetaxel and S-1 in combination ...
A multi-institution phase II study of docetaxel and S-1 in combination ...
Table 1 from Open-labeled, multicenter phase II study of prophylactic ...
Table 1 from Open-labeled, multicenter phase II study of prophylactic ...
(PDF) A phase II study of gemcitabine and docetaxel combination in ...
(PDF) A phase II study of gemcitabine and docetaxel combination in ...
Table 1 from Multicenter phase II study evaluating docetaxel and ...
Table 1 from Multicenter phase II study evaluating docetaxel and ...
Table 1 from A phase II trial of carboplatin and docetaxel followed by ...
Table 1 from A phase II trial of carboplatin and docetaxel followed by ...
Table 1 from NESC Multicenter Phase II Trial in the Preoperative ...
Table 1 from NESC Multicenter Phase II Trial in the Preoperative ...
Table 1 from Phase II study of modified docetaxel, cisplatin, and ...
Table 1 from Phase II study of modified docetaxel, cisplatin, and ...
Table 1 from Phase I trial of combination chemotherapy with docetaxel ...
Table 1 from Phase I trial of combination chemotherapy with docetaxel ...
Table I. | A Phase I/II Study of Docetaxel and Gemcitabine Combination ...
Table I. | A Phase I/II Study of Docetaxel and Gemcitabine Combination ...
Multicenter phase II study of docetaxel plus oxaliplatin combination ...
Multicenter phase II study of docetaxel plus oxaliplatin combination ...
Table 1 from Phase I study of docetaxel, cisplatin and S-1 in patients ...
Table 1 from Phase I study of docetaxel, cisplatin and S-1 in patients ...
A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus ...
A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus ...
Table 1 from NESC Multicenter Phase II Trial in the Preoperative ...
Table 1 from NESC Multicenter Phase II Trial in the Preoperative ...
A phase II study of the combination of docetaxel and bevacizumab for ...
A phase II study of the combination of docetaxel and bevacizumab for ...
(PDF) A multicenter phase II study of Q3 week or weekly paclitaxel in ...
(PDF) A multicenter phase II study of Q3 week or weekly paclitaxel in ...
Figure 1 from Phase I/II Study of Bortezomib Plus Docetaxel in Patients ...
Figure 1 from Phase I/II Study of Bortezomib Plus Docetaxel in Patients ...
(PDF) Phase II multicentre study of docetaxel plus cisplatin in ...
(PDF) Phase II multicentre study of docetaxel plus cisplatin in ...
(PDF) A multicenter, non-randomized, phase II study of docetaxel and ...
(PDF) A multicenter, non-randomized, phase II study of docetaxel and ...
Phase II studies of docetaxel and vinorelbine in NSCLC. | Download Table
Phase II studies of docetaxel and vinorelbine in NSCLC. | Download Table
Table 1 from Multicenter phase III randomized trial comparing docetaxel ...
Table 1 from Multicenter phase III randomized trial comparing docetaxel ...
A multicentre phase II study of docetaxel 75 mg m-2 as first-line ...
A multicentre phase II study of docetaxel 75 mg m-2 as first-line ...

Related Searches

Table 1 from A Multicenter Phase II Study of Docetaxel in Combination ... Table 1 from A Phase II Study of Weekly Docetaxel in Combination with ... Table 1 from A Phase II Study of Weekly Docetaxel for Patients with ... Table 1 from Phase II study of weekly docetaxel in patients with ... Table 1 from A Phase II Study of Weekly Docetaxel as Second-Line ... Table 1 from A Phase Ib/II Study of Gemcitabine and Docetaxel in ... Figure 1 from A Multicenter Randomized Phase II Study of Docetaxel vs ... Table 1 from A prospective multicenter phase II study of oral and i.v ...

Loading image details...

Source
Dimensions
Download

More to explore